Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | KMO | O15229 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12166373 | 1.00 | GP6 (0.35) | GP6MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL12166380 | 0.99 | GP6 (0.36) | GP6MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL12166382 | 0.96 | GP6 (0.34) | GP6MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL12166372 | 0.96 | L3MBTL1 (0.35) | GP6MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL12166355 | 0.96 | L3MBTL1 (0.33) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL12166390 | 0.94 | GP6 (0.35) | GP6MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL12166385 | 0.94 | GP6 (0.35) | GP6MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL12166389 | 0.94 | MEN1 (0.32) | GP6MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL12166348 | 0.91 | L3MBTL1 (0.38) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL12166381 | 0.90 | L3MBTL1 (0.35) | GP6MEN1ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120228554-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-09-13 | — | — | US | disclosed |
| US-20120228554-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120228554-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SLCO4C1, SLCO2B1, SLCO2A1 | GP6 773/4885MEN1 665/4885ALDH1A1 2905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.